Status:

RECRUITING

Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome

Lead Sponsor:

Genethon

Collaborating Sponsors:

Hansa Biopharma AB

Conditions:

Crigler-Najjar Syndrome

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Clinical trial rationale: CNS is an ultra-rare (\<1/1 million newborns), autosomal recessive disorder of bilirubin conjugation caused by mutation in the gene coding for uridine 5'-diphosphate glucuro...

Eligibility Criteria

Inclusion

  • Main
  • Severe Crigler-Najjar syndrome requiring ≥ 6 hours/ day of phototherapy
  • Molecular confirmation of mutation in the UGT1A1gene by DNA sequencing
  • Detectable serum neutralizing antibodies against AAV8
  • Laboratory parameters value not clinically significant
  • Highly effective method of contraception
  • Affiliated to or a beneficiary of a health care system

Exclusion

  • Participation in another interventional trial within 6 months prior to start of clinical trial intervention and during the whole clinical trial
  • Fibrosis score ≥ 3 (METAVIR) or 10 kPa (FibroScan®)
  • Liver transplantation
  • Significant underlying liver disease, chronic hepatitis B, C and/or infected with Human immunodeficiency virus
  • Any other clinically significant illness
  • Uncontrolled hyperlipidemia.
  • History of major thrombotic events, active peripheral vascular disease, proven hypercoagulable conditions,
  • History or presence of thrombotic thrombocytopenic purpura (TTP) or known familial history of TTP
  • Prior or current treatment with Gene therapy, cell based therapy, CRISPR/Cas9 or any other form of gene editing, imlifidase

Key Trial Info

Start Date :

November 8 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2030

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT06518005

Start Date

November 8 2024

End Date

September 30 2030

Last Update

December 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hopital Antoine BECLERE

Clamart, France, 92141